WILLIAM EISENMAN: Open Payments
NPI 1740793793 · DEFIANCE, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$332 in 20 payments from 11 companies in 2025. Trend: 2023 $522 · 2024 $102 · 2025 $332
Food & beverage: $332
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $76 |
| Exact Sciences Corporation | 2 | $37 |
| Abbott Laboratories | 2 | $36 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $35 |
| Lilly USA, LLC | 2 | $34 |
| Novo Nordisk Inc | 2 | $30 |
| Amgen Inc. | 1 | $19 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $19 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $15 |
| Aimmune Therapeutics, Inc. | 1 | $15 |
Products named: QULIPTA, Cologuard Collection Kit, FREESTYLE LIBRE 3, CAPLYTA, MOUNJARO, OTEZLA, XIFAXAN, UBRELVY.
Industry payments across OH — which companies pay providers there.
